MEDOPOLE; an Oman registered Biotech company established in 2021 (Muscat CR N° 1399718).
This company is depicted as a key point in Oman, which affects all facets of healthcare in particular.
Being a specific center in the Sultanate to manage and carry out the goal of presenting health services across different medical disciplines using the most up-to-date tools and best technology.
This gives it respect and prestige among pharmaceutical companies, both nationally as well as internationally.
Our company offers laboratory services and pharmaceutical products that are distinctive in the medicine field around the world.
Our Vision is to enhance community well-being by consistently raising the quality of the products and services we provide, protecting our patients' health and safety, and satisfying our clients and all other interested parties.
We hope to further science through these various Missions, which will enable us to better the lives of thousands of patients afflicted with the pathologies we are studying.
Discovering novel biological compounds to be used in the production of medications.
Developing a medication for the treatment of multiple diseases.
Expanding new, high-tech technology to help detect cancer early.
CHIEF EXECUTIVE OFFICER